Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 18/20 | 0.83 |
| ▸ | CTSL | P07711 | 18/20 | 0.83 |
| ▸ | CTSS | P25774 | 14/20 | 0.83 |
| ▸ | CTSB | P07858 | 6/20 | 0.75 |
| ▸ | CTSV | O60911 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5971184 | 0.87 | CTSK (0.83) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL7426487 | 0.85 | CTSK (0.79) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL4791582 | 0.85 | CTSK (1.00) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL7533565 | 0.85 | CTSK (0.61) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL7478030 | 0.85 | CTSK (1.00) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL7491445 | 0.85 | CTSK (0.77) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL14131370 | 0.84 | CTSK (1.00) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL7488463 | 0.84 | CTSK (0.75) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL8246857 | 0.84 | CTSK (1.00) | CTSKCTSLCTSSCTSBCTSV | |
| SCHEMBL15281233 | 0.84 | CTSK (1.00) | CTSKCTSLCTSSCTSBCTSV |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1303281-A4 | METHODS OF TREATMENT | SMITHKLINE BEECHAM CORP (US) | 2006-02-15 | — | — | EP | claimed |
| JP-2003531122-A | — | — | 2003-10-21 | — | — | JP | claimed |
| EP-1303281-A1 | METHODS OF TREATMENT | SmithKline Beecham Corporation (US) | 2003-04-23 | — | — | EP | claimed |
| WO-2001078734-A1 | METHODS OF TREATMENT | SMITHKLINE BEECHAM CORPORATION (US) | 2001-10-25 | — | — | WO | claimed |
| EP-1320370-A4 | METHOD OF TREATMENT | SMITHKLINE BEECHAM CORP (US) | 2008-10-22 | — | — | EP | disclosed |
| EP-1307204-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2004-06-02 | — | — | EP | disclosed |
| EP-1320370-A1 | METHOD OF TREATMENT | SmithKline Beecham Corporation (US) | 2003-06-25 | — | — | EP | disclosed |
| EP-1307204-A1 | PROTEASE INHIBITORS | SmithKline Beecham Corporation (US) | 2003-05-07 | — | — | EP | disclosed |
| EP-1158986-A4 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORP (US) | 2002-03-27 | — | — | EP | disclosed |
| WO-2002017924-A1 | METHOD OF TREATMENT | SMITHKLINE BEECHAM CORPORATION (GB) | 2002-03-07 | — | — | WO | disclosed |
| WO-2001095911-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2001-12-20 | — | — | WO | disclosed |
| EP-1158986-A1 | PROTEASE INHIBITORS | SmithKline Beecham Corporation (US) | 2001-12-05 | — | — | EP | disclosed |
| WO-2000038687-A1 | PROTEASE INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-06 | — | — | WO | disclosed |